Aplion’s President Brad Stewart was quoted as saying: “We are very pleased to have NHT, give their support to Aplion and the Aplion Topical Delivery System.’
The Aplion Topical Delivery System allows the Physician to Individualize the treatment of chronic wounds with a portable device about half the size on your cell phone. This completely device automatically treats the patient wound for up to 7 days with little to no interaction necessary for the patient
Greg Ensey President of NHT said “Aplion’s Wound Care device shows great potential in the market place and we are excited to contribute to Aplions succes in offering patients with hard to heal wounds a great new alternative treatment modality.”
In addition to empowering the physician to select the best possible treatment for each patients needs the Aplion TDS ensures compliance with the treatment plan by virtue of its automated nature says Stewart. With IHCs support we hope to make the device available to physicians and patients as soon as possible.
NHT Global Partners is a privately held investment company incorporated in Singapore..
Aplion Medical Corporation based in Salt Lake City, Utah is a medical device company focused on meeting the wound care needs of patients and providers in a range of healthcare settings. Aplion’s focus is to contribute to the well fair and recovery of patients with chronic and hard to heal wounds. Visit us at AplionMedical.com.